A Bioinspired Lung Alveoli Model with Physiological Relevance for Drug Discovery Research
Olivier Guenat, Head, Organs-on-Chip Technologies, ARTORG Center for Biomedical Engineering Research, University of Bern-Switzerland
The high attrition rate and the huge costs related to the drug
development process have recently led to the emergence of advanced
in-vitro models that better reproduce the cellular and
biophysical/-chemical environment found in-vivo. In contrast to standard
in-vitro systems, these models, called organs-on-chip, are expected to
better predict drugs’s response in humans and are thus widely seen as
having the potential to revolutionize the way drug discovery is made.
The objectives of the ARTORG Lung Regeneration Technologies Lab are the
development of advanced in-vitro models able to mimic specific
parameters of the environment of healthy or diseased lungs. These
systems, based on microfluidics, are aimed at better understanding the
pathophysiology and –mechanism of specific respiratory diseases. One of
the research directions under investigation in the lab focuses on the
reproduction of a healthy and diseased (lung fibrosis) lung alveolar
environment. A bioinspired microfluidic chip mimicking the air-blood
barrier was developed that reproduces the cyclic mechanical strain
induced by the respiration. Permeability assays performed with bronchial
cell line revealed the effect of the mechanical strain as well as the
size of the molecules studied. In a second set of experiment, primary
epithelial cells from patients undergoing partial lung resection were
exposed to cyclic stretch during 24h. The effect of the stretch was
clearly demonstrated on those cells with a clear increase of
inflammation marker IL-8 compared to the cells were cultured in a static
mode. Finally, a model aimed at reproducing the alveolar epithelial
microinjuries that are typical to pulmonary fibrosis will be shown.
|
|